{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:56:34Z","timestamp":1785916594276,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00392-007-0602-0","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T09:54:29Z","timestamp":1196502869000},"page":"152-159","source":"Crossref","is-referenced-by-count":15,"title":["Productivity loss as a major component of disease-related costs in patients with hypercholesterolemia in Germany"],"prefix":"10.1007","volume":"97","author":[{"given":"Jacqueline","family":"M\u00fcller-Nordhorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Englert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Wegscheider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrike","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Sonntag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"V\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Meyer-Sabellek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reinhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Windler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo A.","family":"Katus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan N.","family":"Willich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,1]]},"reference":[{"key":"602_CR1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.CIR.83.1.356","volume":"83","author":"KM Anderson","year":"1991","unstructured":"Anderson KM, Wilson PW, Odell PM, Kannel WB (1991) An updated coronary risk profile. A statement for health professionals. Circulation 83:356\u2013362","journal-title":"Circulation"},{"key":"602_CR2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM et al. (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366:1267\u20131278","journal-title":"Lancet"},{"key":"602_CR3","unstructured":"Bundesministerium f\u00fcr Gesundheit (2002) Statistisches Taschenbuch Gesundheit 2002. Bundesministerium f\u00fcr Gesundheit, Bonn"},{"key":"602_CR4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-8510(01)00178-6","volume":"59","author":"I Cleemput","year":"2002","unstructured":"Cleemput I, Kesteloot K, DeGeest S (2002) A review of the literature on the economics of noncompliance. Room for methodological improvement. Health Policy 59:65\u201394","journal-title":"Health Policy"},{"key":"602_CR5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/07853890109002088","volume":"33","author":"M Drummond","year":"2001","unstructured":"Drummond M (2001) Introducing economic and quality of life measurements into clinical studies. Ann Med 33:344\u2013349","journal-title":"Ann Med"},{"key":"602_CR6","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Executive","year":"2001","unstructured":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001). JAMA 285:2486\u20132497","journal-title":"JAMA"},{"key":"602_CR7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/jech.2005.034900","volume":"59","author":"OH Franco","year":"2005","unstructured":"Franco OH, Peeters A, Looman CW, Bonneux L (2005) Cost effectiveness of statins in coronary heart disease. J Epidemiol Community Health 59:927\u2013933","journal-title":"J Epidemiol Community Health"},{"key":"602_CR8","volume-title":"Gesundheit in Deutschland","author":"Gesundheitsberichterstattung des Bundes","year":"2006","unstructured":"Gesundheitsberichterstattung des Bundes (2006) Gesundheit in Deutschland. Robert Koch-Institut, Berlin"},{"key":"602_CR9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archinte.163.3.333","volume":"163","author":"SA Grover","year":"2003","unstructured":"Grover SA, Ho V, Lavoie F et al. (2003) The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins? Arch Intern Med 163:333\u2013339","journal-title":"Arch Intern Med"},{"key":"602_CR10","first-page":"A62","volume":"4","author":"Hanoverian Consensus-Group","year":"1999","unstructured":"Hanoverian Consensus-Group (1999) German recommendations for health economic evaluations\u2014revised version of the Hanover Consensus. Gesundh \u00d6kon Qual Manag 4:A62\u2013A65","journal-title":"Gesundh \u00d6kon Qual Manag"},{"key":"602_CR11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/euhj.2000.2308","volume":"22","author":"BA Hout van","year":"2001","unstructured":"van Hout BA, Simoons ML (2001) Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat? Eur Heart 22:751\u2013761","journal-title":"Eur Heart"},{"key":"602_CR12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM199701303360503","volume":"336","author":"M Johannesson","year":"1997","unstructured":"Johannesson M, Jonsson B, Kjekshus J et al. (1997) Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. N Engl J Med 336:332\u2013336","journal-title":"N Engl J Med"},{"key":"602_CR13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/PL00002127","volume":"95","author":"G Klever-Deichert","year":"2000","unstructured":"Klever-Deichert G, Hinzpeter B, Wendland G, Lauterbach K (2000) Cost-benefit analysis of an evidence-based secondary prevention of coronary heart diseases by statins. An analysis for Germany from a social security perspective. Med Klin (Munich) 95:305\u2013313","journal-title":"Med Klin (Munich)"},{"issue":"suppl","key":"602_CR14","first-page":"VI17","volume":"95","author":"C Luley","year":"2006","unstructured":"Luley C (2006) Lipometabolic disorder\u2014cholesterol and triglycerides. Clin Res Cardiol 95(suppl):VI17\u2013VI22","journal-title":"Clin Res Cardiol"},{"key":"602_CR15","unstructured":"MediMedia GmbH (2002) Gelbe Liste Pharmindex ( http:\/\/www.gelbe-liste.de ). MediMedia GmbH, Neu-Isenburg"},{"key":"602_CR16","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(05)63014-0","volume":"365","author":"B Mihaylova","year":"2005","unstructured":"Mihaylova B, Briggs A, Armitage J et al. (2005) Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals. Lancet 365:1779\u20131785","journal-title":"Lancet"},{"key":"602_CR17","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.amjcard.2005.01.074","volume":"95","author":"PS Miller","year":"2005","unstructured":"Miller PS, Smith DG, Jones P (2005) Cost effectiveness of rosuvastatin in treating patients to low-density lipoprotein cholesterol goals compared with atorvastatin, pravastatin, and simvastatin (a US Analysis of the STELLAR Trial). Am J Cardiol 95:1314\u20131319","journal-title":"Am J Cardiol"},{"key":"602_CR18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2036.2005.02570.x","volume":"22","author":"J M\u00fcller-Nordhorn","year":"2005","unstructured":"M\u00fcller-Nordhorn J, Br\u00fcggenj\u00fcrgen B, B\u00f6hmig M et al. (2005) Direct and indirect costs in a prospective cohort of patients with pancreatic cancer. Aliment Pharmacol Ther 22:405\u2013415","journal-title":"Aliment Pharmacol Ther"},{"key":"602_CR19","unstructured":"M\u00fcller-Nordhorn J, Reinhold T, Sonntag F, Wegscheider K, Willich SN (2007) Projected trends in costs of patients with hypercholesterolemia in Germany. E-J Cardiol Practice 6"},{"key":"602_CR20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(03)12655-4","volume":"361","author":"CJ Murray","year":"2003","unstructured":"Murray CJ, Lauer JA, Hutubessy RC et al. (2003) Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 361:717\u2013725","journal-title":"Lancet"},{"key":"602_CR21","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0959-8049(99)00216-6","volume":"35","author":"N Neymark","year":"1999","unstructured":"Neymark N, Adriaenssen I (1999) The costs of managing patients with advanced colorectal cancer in 10 different European centres. Eur J Cancer 35:1789\u20131795","journal-title":"Eur J Cancer"},{"key":"602_CR22","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1053\/euhj.1998.1243","volume":"19","author":"Prevention","year":"1998","unstructured":"Prevention of coronary heart disease in clinical practice (1998) Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 19:1434\u20131503","journal-title":"Eur Heart J"},{"key":"602_CR23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.7326\/0003-4819-132-10-200005160-00002","volume":"132","author":"LA Prosser","year":"2000","unstructured":"Prosser LA, Stinnett AA, Goldman PA et al. (2000) Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med 132:769\u2013779","journal-title":"Ann Intern Med"},{"key":"602_CR24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1468-1331.2005.01091.x","volume":"12","author":"K Rossnagel","year":"2005","unstructured":"Rossnagel K, Nolte CH, M\u00fcller-Nordhorn J et al. (2005) Medical resource use and costs of health care after acute stroke in Germany. Eur J Neurol 12:862\u2013868","journal-title":"Eur J Neurol"},{"key":"602_CR25","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/art.20686","volume":"51","author":"J Ruof","year":"2004","unstructured":"Ruof J, Huelsemann JL, Mittendorf T et al. (2004) Patient-reported health care utilization in rheumatoid arthritis: what level of detail is required? Arthritis Rheum 51:774\u2013781","journal-title":"Arthritis Rheum"},{"key":"602_CR26","first-page":"15","volume-title":"Gesundheits\u00f6konomie - Grundlagen und Praxis","author":"R Rychlik","year":"1999","unstructured":"Rychlik R (1999) Gesundheits\u00f6konomie - Grundlagen und Praxis. Enke, Stuttgart, pp 15\u2013172"},{"key":"602_CR27","volume-title":"Arzneiverordnungsreport 2002","author":"U Schwabe","year":"2002","unstructured":"Schwabe U, Pfaff D (2002) Arzneiverordnungsreport 2002. Springer-Verlag, Berlin"},{"key":"602_CR28","volume-title":"Die Bev\u00f6lkerung Deutschlands bis 2050. 10. koordinierte Bev\u00f6lkerungsvorausberechnung","author":"Statistisches Bundesamt","year":"2003","unstructured":"Statistisches Bundesamt (2003) Die Bev\u00f6lkerung Deutschlands bis 2050. 10. koordinierte Bev\u00f6lkerungsvorausberechnung. Statistisches Bundesamt, Bonn"},{"key":"602_CR29","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/oxfordjournals.eurheartj.a015166","volume":"18","author":"TE Strandberg","year":"1997","unstructured":"Strandberg TE, Lehto S, Pyorala K et al. (1997) Cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland. Eur Heart J 18:1725\u20131727","journal-title":"Eur Heart J"},{"key":"602_CR30","unstructured":"Verband deutscher Rentenversicher ungstr\u00e4ger (VDR) (2003) Durchschnittliche Bruttojahresarbeitsentgelte ( http:\/\/www.vdr.de\/internet\/vdr\/statzr.nsf\/ ). Verband deutscher Rentenversicherungstr\u00e4ger, Frankfurt am Main"},{"key":"602_CR31","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ahj.2004.05.032","volume":"148","author":"SN Willich","year":"2004","unstructured":"Willich SN, M\u00fcller-Nordhorn J, Sonntag F et al. (2004) Economic evaluation of a compliance-enhancing intervention in patients with hypercholesterolemia: design and baseline results of the Open Label Primary Care Study: rosuvastatin based compliance initiatives to achievements of LDL goals (ORBITAL) study. Am Heart J 148:1060\u20131067","journal-title":"Am Heart J"},{"key":"602_CR32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF03321561","volume":"3","author":"SN Willich","year":"2005","unstructured":"Willich SN, Reinhold T, Lenz C, Br\u00fcggenj\u00fcrgen B (2005) Herzinsuffizienz nach Myokardinfarkt in Deutschland \u2013 \u00d6konomische Bedeutung und Einschr\u00e4nkung der Lebensqualit\u00e4t. Pharmacoecon \u2013 German Res Art 3:25\u201339","journal-title":"Pharmacoecon \u2013 German Res Art"},{"key":"602_CR33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2036.2006.02763.x","volume":"23","author":"SN Willich","year":"2006","unstructured":"Willich SN, Nocon M, Kulig M et al. (2006) Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett\u2019s mucosa. Aliment Pharmacol Ther 23:371\u2013376","journal-title":"Aliment Pharmacol Ther"},{"key":"602_CR34","volume-title":"The World Health Report 2002. Reducing risks, promoting healthy life","author":"World Health Organization","year":"2003","unstructured":"World Health Organization (2003) The World Health Report 2002. Reducing risks, promoting healthy life. World Health Organization, Geneva"},{"key":"602_CR35","unstructured":"Zentralinstitut f\u00fcr die kassen\u00e4rztliche Versorgung in der BRD (2002) Die 50 h\u00e4ufigsten Diagnosen von Patienten, Kontakth\u00e4ufigkeit und angeforderter Leistungsbedarf in Punkten. Zentralinstitut f\u00fcr kassen\u00e4rztliche Versorgung, K\u00f6ln"},{"key":"602_CR36","doi-asserted-by":"crossref","first-page":"752","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00063","volume":"127","author":"XH Zhou","year":"1997","unstructured":"Zhou XH, Melfi CA, Hui SL (1997) Methods for comparison of cost data. Ann Intern Med 127:752\u2013756","journal-title":"Ann Intern Med"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-007-0602-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-007-0602-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-007-0602-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:21:52Z","timestamp":1559060512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-007-0602-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,1]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["602"],"URL":"https:\/\/doi.org\/10.1007\/s00392-007-0602-0","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,1]]}}}